Anika Therapeutics (ANIK) Return on Invested Capital (2011 - 2023)

Anika Therapeutics (ANIK) has 7 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2023.

• On a quarterly basis, Return on Invested Capital fell 1.0% year-over-year to 0.01% in Q1 2023; TTM through Mar 2023 was 0.01%, a 1.0% decrease from a year earlier, with the FY2021 full-year figure at 0.0%, changed N/A from the prior year.
• Return on Invested Capital for Q1 2023 stood at 0.01%, down from 0.0% in the prior quarter.
• Over the last five years, Return on Invested Capital for ANIK reached as high as 0.0% in Q4 2022 and fell as low as 0.01% in Q3 2022.
• Historically, Return on Invested Capital has averaged 0.0% across 3 years, with a median of 0.0% in 2021.
• On a YoY basis, Return on Invested Capital climbed as much as 0 bps in 2022 and fell as far as 1 bps in 2022.
• Year by year, Return on Invested Capital stood at 0.0% in 2021, then jumped by 1050 bps to 0.0% in 2022, then slumped by 721 bps to 0.01% in 2023.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.01% in Q1 2023, 0.0% in Q4 2022, and 0.01% in Q3 2022.